🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brett Lowe

London School of Hygiene & Tropical Medicine

ORCID: 0000-0002-4422-8627

MedicineImmunology and MicrobiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial”.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial

The Lancet Global Health(2022)10.1016/s2214-109x(22)00309-6

N/A

4.4DataRank · unranked

117 citations

John Changalucha, Hilary Whitworth, Lígia A. Pinto, Paul Mutani, Jackton Indangasi +18 more

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00125-0

N/A

1.7DataRank · unranked

95 citations

Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro, Viki Bockstal, Baimba Rogers +87 more

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Clinical Infectious Diseases(2023)10.1093/cid/ciad693

N/A

0.671DataRank · unranked

16 citations

Ken Liu, Édouard Lhomme, Julie Blie, John McCullough, Matthew Onorato +90 more

Implementation of Good Clinical Laboratory Practice in an Immunology Basic Research Laboratory

American Journal of Clinical Pathology(2019)10.1093/ajcp/aqy138

N/A

0.396DataRank · unranked

13 citations

Jennifer Musyoki, Moses Mosobo, Brett Lowe, Horace Gumba

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols

PLoS ONE(2022)10.1371/journal.pone.0270968

N/A

0DataRank · unranked

11 citations

Suzanne Fleck, Bailah Leigh, Philip Ayieko, Daniel Tindanbil, Tuda Otieno +12 more

Immunogenicity and Safety of One-Dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-Label, Randomised, Non-inferiority Trial

Obstetrical & Gynecological Survey(2023)10.1097/ogx.0000000000001135

N/A

0DataRank · unranked

1 citations

John Changalucha, Hilary Whitworth, Lígia A. Pinto, Paul Mutani, Jackton Indangasi +18 more

Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial

npj Vaccines(2025)10.1038/s41541-025-01313-8

N/A

0DataRank · unranked

0 citations

Kathy Baisley, Jackton Indangasi, John Changalucha, Helen Ashwin, Najmeeyah Brown +16 more